Dexcom Inc
NASDAQ:DXCM
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
64
140.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Dexcom Inc
Dexcom Inc
Capital Expenditures
Dexcom Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Capital Expenditures
-$286.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-35%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Capital Expenditures
-$725m
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Capital Expenditures
-$780m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
|
Stryker Corp
NYSE:SYK
|
Capital Expenditures
-$634m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
|
|
Abbott Laboratories
NYSE:ABT
|
Capital Expenditures
-$2.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Capital Expenditures
-$1.2B
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-33%
|
|
Dexcom Inc
Glance View
Dexcom Inc. is a pioneering company at the forefront of diabetes management, focusing on continuous glucose monitoring (CGM) systems that empower individuals with diabetes to better manage their condition. Founded in 1999, Dexcom revolutionized the way patients track their glucose levels by offering real-time data through wearable sensor technology. This innovation not only enhances the quality of life for users by providing insights into their glucose fluctuations but also improves clinical outcomes, as patients can make informed decisions about their diet, exercise, and medication. With a firm commitment to research and development, Dexcom continuously invests in advanced technologies, such as smart devices and integrated platforms, to stay ahead in a competitive market. For investors, Dexcom presents a compelling opportunity given its strong growth trajectory and expanding market reach. The company has seen robust revenue growth, fueled by increasing diabetes prevalence and a shift towards more proactive health management solutions. Dexcom's strategic partnerships with major healthcare players and integrations with mobile applications further enhance its market position. As healthcare evolves, the demand for seamless and user-friendly monitoring solutions is likely to rise, placing Dexcom in a prime position to capitalize on this growing trend. With strong intellectual property, a loyal customer base, and a focused vision for future innovation, Dexcom stands as a promising investment for those looking to enter the healthcare sector.
See Also
What is Dexcom Inc's Capital Expenditures?
Capital Expenditures
-286.7m
USD
Based on the financial report for Sep 30, 2024, Dexcom Inc's Capital Expenditures amounts to -286.7m USD.
What is Dexcom Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-35%
Over the last year, the Capital Expenditures growth was -16%. The average annual Capital Expenditures growth rates for Dexcom Inc have been 8% over the past three years , -13% over the past five years , and -35% over the past ten years .
You don't have any saved screeners yet
